Select Publications
Journal articles
2020, 'HIV stigma by association among Australian gay and bisexual men.', AIDS, 34 Suppl 1, pp. S53 - S62, http://dx.doi.org/10.1097/QAD.0000000000002565
,2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085
,2020, 'Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study', JOURNAL OF HEPATOLOGY, 73, pp. S127 - S127, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587000206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2019-034389
,2020, 'The role of social support in moderating the relationship between HIV centrality, internalised stigma and psychological distress for people living with HIV', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 32, pp. 850 - 857, http://dx.doi.org/10.1080/09540121.2019.1659914
,2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15113
,2020, 'Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use', International Journal of Drug Policy, 78, http://dx.doi.org/10.1016/j.drugpo.2020.102697
,2020, 'Stigmatising attitudes towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections in a representative sample of the Australian population', PLoS ONE, 15, http://dx.doi.org/10.1371/journal.pone.0232218
,2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225
,2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233
,2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693
,2020, 'Stigma, Anxiety, and Depression Among Gay and Bisexual Men in Mixed-Orientation Marriages', Qualitative Health Research, 30, pp. 622 - 633, http://dx.doi.org/10.1177/1049732319862536
,2020, 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', Addictive Behaviors, 101, http://dx.doi.org/10.1016/j.addbeh.2019.106144
,2020, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs: Education, Prevention and Policy, 27, pp. 92 - 94, http://dx.doi.org/10.1080/09687637.2019.1583170
,2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705
,2020, 'Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure', International Journal of Drug Policy, 75, http://dx.doi.org/10.1016/j.drugpo.2019.11.004
,2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698
,2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135
,2019, 'Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all', International Journal of Drug Policy, 72, pp. 1 - 10, http://dx.doi.org/10.1016/j.drugpo.2019.07.016
,2019, 'Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals', International Journal of Drug Policy, 72, pp. 77 - 83, http://dx.doi.org/10.1016/j.drugpo.2019.06.002
,2019, 'Involving peers in research: The UNSW community reference panel', Harm Reduction Journal, 16, http://dx.doi.org/10.1186/s12954-019-0325-3
,2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112
,2019, 'Feasibility of a Mobile Health App for Routine Outcome Monitoring and Feedback in Mutual Support Groups Coordinated by SMART Recovery Australia: Protocol for a Pilot Study (Preprint)', , http://dx.doi.org/10.2196/preprints.15113
,2019, 'Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination', Critical Public Health, 29, pp. 260 - 273, http://dx.doi.org/10.1080/09581596.2018.1459475
,2019, 'Predictors of health care workers’ support for discriminatory treatment and care of people who inject drugs', Psychology, Health and Medicine, 24, pp. 439 - 445, http://dx.doi.org/10.1080/13548506.2018.1546018
,2019, 'Acceptability of Patient-Reported Outcome and Experience Measures for Hepatitis C Treatment Among People Who Use Drugs', Patient, 12, pp. 259 - 265, http://dx.doi.org/10.1007/s40271-018-0332-6
,2019, 'Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs', International Journal of Drug Policy, 66, pp. 87 - 93, http://dx.doi.org/10.1016/j.drugpo.2019.01.012
,2019, 'Lives of Substance: a mixed-method evaluation of a public information website on addiction experiences', Drugs: Education, Prevention and Policy, 26, pp. 140 - 147, http://dx.doi.org/10.1080/09687637.2017.1397602
,2019, 'A web-based therapeutic program (We Can Do This) for reducing methamphetamine use and increasing help-seeking among aboriginal and torres strait islander people: Protocol for a randomized wait-list controlled trial', Journal of Medical Internet Research, 21, http://dx.doi.org/10.2196/14084
,2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013
,2019, 'Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework', Liver International, 39, pp. 20 - 30, http://dx.doi.org/10.1111/liv.13949
,2018, 'Responding to a national policy need: development of a stigma indicator for bloodborne viruses and sexually transmissible infections', Australian and New Zealand Journal of Public Health, 42, pp. 513 - 515, http://dx.doi.org/10.1111/1753-6405.12809
,2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987
,2018, 'Health protection and Australian prisons, 2018', The Medical Journal of Australia, 209, pp. 460 - 461, http://dx.doi.org/10.5694/mja18.00669
,2018, 'Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia', International Journal of Drug Policy, 61, pp. 23 - 30, http://dx.doi.org/10.1016/j.drugpo.2018.08.011
,2018, 'Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?', PLoS ONE, 13, http://dx.doi.org/10.1371/journal.pone.0207226
,2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141
,2018, 'Beyond cure: Patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia', Harm Reduction Journal, 15, http://dx.doi.org/10.1186/s12954-018-0248-4
,2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, 15, http://dx.doi.org/10.1186/s12954-018-0246-6
,2018, 'Building on feminist achievements to enhance choice for women seeking treatment', Addiction, 113, pp. 1001 - 1002, http://dx.doi.org/10.1111/add.14226
,2018, 'Do women with complex alcohol and other drug use histories want women-only residential treatment?', Addiction, 113, pp. 989 - 997, http://dx.doi.org/10.1111/add.14131
,2018, 'A239 QUALITATIVE EVALUATION OF THE DECISIONS AND EXPERIENCES OF PEOPLE WHO INJECT DRUGS WHO RECEIVED A LIVER DISEASE ASSESSMENT AS PART OF A LIVER HEALTH PROMOTION CAMPAIGN: THE LIVERLIFE STUDY', Journal of the Canadian Association of Gastroenterology, 1, pp. 419 - 419, http://dx.doi.org/10.1093/jcag/gwy008.240
,2018, 'Evaluation of the Deadly Liver Mob program: Insights for roll-out and scale-up of a pilot program to engage Aboriginal Australians in hepatitis C and sexual health education, screening, and care', Harm Reduction Journal, 15, http://dx.doi.org/10.1186/s12954-018-0209-y
,2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030
,2017, '‘Affording’ new approaches to couples who inject drugs: A novel fitpack design for hepatitis C prevention', International Journal of Drug Policy, 50, pp. 19 - 35, http://dx.doi.org/10.1016/j.drugpo.2017.07.001
,2017, '‘I didn't want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study', International Journal of Drug Policy, 47, pp. 153 - 160, http://dx.doi.org/10.1016/j.drugpo.2017.06.001
,2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562
,2017, 'Diffracting addicting binaries: An analysis of personal accounts of alcohol and other drug ‘addiction’', Health (United Kingdom), 21, pp. 519 - 537, http://dx.doi.org/10.1177/1363459316674062
,2017, 'Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy', International Journal of Drug Policy, 47, pp. 26 - 33, http://dx.doi.org/10.1016/j.drugpo.2017.08.001
,2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701
,